Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 1998, p. 1375-1381, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Recombinant Expression and Characterization of the
Major
-Lactamase of Mycobacterium tuberculosis
Rama Kishan R.
Voladri,1
David L.
Lakey,1,2
Steven H.
Hennigan,1
Barbara E.
Menzies,1,3
Kathryn M.
Edwards,2 and
Douglas S.
Kernodle1,3,*
Divisions of Infectious Disease, Department
of Medicine,1 and
Division of Infectious
Diseases, Department of Pediatrics,2
Vanderbilt University School of Medicine, Nashville, Tennessee
37232-2605, and
Department of Veterans Affairs Medical
Center, Nashville, Tennessee 372123
Received 22 August 1997/Returned for modification 5 December
1997/Accepted 15 March 1997
 |
ABSTRACT |
New antibiotic regimens are needed for the treatment of
multidrug-resistant tuberculosis. Mycobacterium
tuberculosis has a thick peptidoglycan layer, and the
penicillin-binding proteins involved in its biosynthesis are inhibited
by clinically relevant concentrations of
-lactam antibiotics.
-Lactamase production appears to be the major mechanism by which
M. tuberculosis expresses
-lactam resistance.
-Lactamases from the broth supernatant of 3- to 4-week-old cultures
of M. tuberculosis H37Ra were partially purified by
sequential gel filtration chromatography and chromatofocusing. Three
peaks of
-lactamase activity with pI values of 5.1, 4.9, and 4.5, respectively, and which accounted for 10, 78, and 12% of the total
postchromatofocusing
-lactamase activity, respectively, were
identified. The
-lactamases with pI values of 5.1 and 4.9 were
kinetically indistinguishable and exhibited predominant penicillinase activity. In contrast, the
-lactamase with a pI value of 4.5 showed
relatively greater cephalosporinase activity. An open reading frame in
cosmid Y49 of the DNA library of M. tuberculosis H37Rv with homology to known class A
-lactamases was amplified from chromosomal DNA of M. tuberculosis H37Ra by PCR and
was overexpressed in Escherichia coli. The recombinant
enzyme was kinetically similar to the pI 5.1 and 4.9 enzymes purified
directly from M. tuberculosis. It exhibited
predominant penicillinase activity and was especially active against
azlocillin. It was inhibited by clavulanic acid and
m-aminophenylboronic acid but not by EDTA. We conclude that the major
-lactamase of M. tuberculosis is a class
A
-lactamase with predominant penicillinase activity. A second,
minor
-lactamase with relatively greater cephalosporinase activity
is also present.
 |
INTRODUCTION |
Tuberculosis causes 3 million deaths
annually, more than any other single infectious agent (2, 19,
35). Multidrug resistance is a growing clinical problem, with
strains of Mycobacterium tuberculosis exhibiting resistance
to 11 or more antimicrobial agents having been described
(25). Although it was shown in the 1940s that under certain
culture conditions penicillin inhibits the growth of M. tuberculosis (9, 10, 18, 31), the availability of other
effective antimicrobial agents limited efforts to determine whether
tuberculosis might respond to treatment with
-lactams. However, the
recent rise in infections caused by multidrug-resistant strains has
made it necessary to identify alternative treatment regimens, including
the determination of whether some older classes of antibiotics such as
the
-lactams might be effective in the clinical setting.
The cell wall structure of M. tuberculosis contains a
thick peptidoglycan layer. Cycloserine, a second-line drug in the
treatment of tuberculosis, is a D-alanine analog that
interferes with peptidoglycan synthesis (37). Recently, it
has been shown that M. tuberculosis makes at least four
penicillin-binding proteins (PBPs) that bind ampicillin and other
-lactams at clinically relevant antibiotic concentrations
(3). The affinities of these agents for their PBP targets
are of the magnitude seen for
-lactams that can be effectively used
for the treatment of infections caused by other microbes. Also, the
outer cellular structures of tubercle bacilli do not represent a major
permeability barrier for
-lactams (3, 22). Therefore, the
production of
-lactamase by M. tuberculosis appears
to be its major mechanism of resistance to
-lactams.
Most and possibly all isolates of M. tuberculosis
produce
-lactamase (12, 13, 15, 42); however, data
regarding its nature are limited. Opinions differ as to whether it is
secreted, cytoplasmic, or bound to the cell membrane and as to whether
its production is inducible or constitutive (10, 14, 15, 32, 42). Zhang et al. (42) have reported that isoelectric
focusing of Triton X-100 extracts of acetone-precipitated cell pellets of strains of M. tuberculosis reveals two bands
exhibiting
-lactamase activity with pI values of 4.9 and 5.1.
Most of the information on the kinetic properties of M. tuberculosis
-lactamase comes from studies with relatively
impure preparations of enzyme or has been inferred indirectly via the results of susceptibility tests involving
-lactams and
-lactam-
-lactamase inhibitor combinations. However,
greater penicillinase activity than cephalosporinase activity is
consistently reported (15, 20, 22, 42). M. tuberculosis
-lactamase is inhibited competitively by
antistaphylococcal penicillins (13-15, 21, 22, 32) and by
conventional
-lactamase inhibitors including clavulanic acid, sulbactam, and tazobactam (5, 8, 33, 38, 41, 42).
-Lactamase inhibitors improve the activities of some penicillins against M. tuberculosis in vitro (5, 8, 14,
33) and in vivo (13). In addition, some cephalosporins
including ceforanide and cephapirin as well as carbapenems such as
imipenem exhibit potent in vitro activities (23, 30, 36).
Because a better understanding of the mechanisms by which M. tuberculosis expresses resistance to
-lactams might ultimately lead to strategies in which these agents could be used in the treatment
of tuberculosis, we have worked to characterize its
-lactamase(s).
In this report, we describe the isolation of three enzymes with
distinct pI values directly from M. tuberculosis and
the recombinant expression and kinetic characterization of the major
enzyme.
(Results of this study were presented in part at the 36th Interscience
Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La.,
15 to 18 September 1996, and at the 32nd U.S.-Japan Conference of
Tuberculosis/Leprosy, Cleveland, Ohio, 21 to 23 July 1997.)
 |
MATERIALS AND METHODS |
Bacterial strains, media, and reagents.
Strain H37Ra (ATCC
25177) is an attenuated laboratory strain of M. tuberculosis. Escherichia coli DH5
was used in routine E. coli transformation experiments, and E. coli Top10 was
used as the host for recombinant protein expression. Middlebrook 7H9 broth media and oleic acid-albumin-dextrose-catalase (OADC) were purchased from Difco Laboratories, Detroit, Mich. G-75 Sephadex (Pharmacia-LKB Biotechnology, Broma, Sweden) was used to construct the
gel filtration column, and DEAE-cellulose (Pharmacia-LKB) was used for
anion-exchange chromatography. Standard powders of nitrocefin (BBL
Microbiology Systems, Cockeysville, Md.), phenoxymethylpenicillin and cephaloridine (Sigma Chemical Company, St. Louis, Mo.), cephapirin (Bristol Laboratories, Syracuse, N.Y.), cefazolin, cephalothin, cefamandole, and benzylpenicillin (Eli Lilly & Company, Indianapolis, Ind.), azlocillin (Miles Inc., West Haven, Conn.), amoxicillin and
clavulanic acid (SmithKline Beecham Pharmaceuticals, Philadelphia, Pa.), and sulbactam (Pfizer Inc., New York, N.Y.) were used to prepare
antibiotic solutions for kinetic studies.
Determination of
-lactamase activity.
-Lactamase
activity was assayed spectrophotometrically with nitrocefin (100 µM)
in 0.1 M sodium phosphate buffer (pH 6.0) as the substrate at 37°C
(26). All determinations were carried out in duplicate. One
unit of
-lactamase activity is defined as the amount required to
hydrolyze 1 nmol of nitrocefin per min. To calculate the amount of
secreted and cell-associated
-lactamase, cells from a 3-week-old
culture of H37Ra in Middlebrook 7H9 media supplemented with OADC and
0.05% Tween 80 (BBL Microbiology Systems) were pelleted by
centrifugation. The cell pellet was resuspended in 0.1 M sodium
phosphate buffer (pH 6.0) and lysed with a Bead Beater (Biospec
Products, Bartlesville, Okla.) for 2 min. The supernatant from the
broth culture and the cell lysate thus obtained were assayed for
-lactamase activity as described above to determine the amounts of
extracellular and cell-associated
-lactamase, respectively.
Purification of
-lactamase directly from M. tuberculosis H37Ra.
M. tuberculosis H37Ra was
inoculated into Middlebrook 7H9 broth media containing OADC and 0.05%
Tween 80 was added to facilitate its growth as dispersed cells rather
than clumps of cells (18, 34). A 4-week-old culture was
harvested and the supernatant was precipitated with ammonium sulfate.
The precipitated pellet obtained by increasing the ammonium sulfate
concentration from 50 to 62.5% was resuspended in 0.1 M sodium citrate
buffer (pH 5.0) and dialyzed overnight in the same buffer.
(i) Gel filtration chromatography.
The crude enzyme
preparation thus obtained was concentrated to 20 ml and was loaded onto
a G-75 column (3 by 90 cm) equilibrated with 0.1 M sodium citrate
buffer (pH 5.0). Elution was continued with the same buffer until the
-lactamase activity was recovered.
(ii) Chromatofocusing chromatography.
The
-lactamase
activity from gel filtration chromatography was exchanged with 25 mM
bis-Tris buffer (pH 6.3) and was loaded onto a Mono P column (HR 5/20
fast-performance liquid chromatography system; Pharmacia-LKB), and the
proteins were eluted with polybuffer (pH 4.0) in a linear gradient
manner.
(iii) Anion-exchange chromatography.
As an alternative to
chromatofocusing, in some experiments anion-exchange chromatography was
performed with a column (3 by 20 cm) and DEAE-cellulose. Fractions from
the gel filtration column exhibiting
-lactamase activity were
pooled, concentrated, and exchanged with 20 mM bis-Tris buffer (pH
6.0). After loading onto and washing of the anion-exchange column with
the same buffer, the
-lactamase was eluted with 20 mM bis-Tris (pH
6.0) containing a linear gradient from 0 to 200 mM NaCl.
Isoelectric focusing of M. tuberculosis
-lactamase.
Each peak fraction of
-lactamase activity
collected independently from the chromatofocusing column was subjected
to isoelectric focusing on a Multiphor electrophoresis system
(Pharmacia Biotech, Piscataway, N.J.). Isoelectric focusing was
performed with commercially available ampholyte polyacrylamide gels (pH
range, 4.0 to 6.5; Pharmacia-LKB Biotechnology). Electrophoresis was
performed at 10°C by using preset values of 1,400 V, 25 mA, and 25 W. After 3 h, the gel was removed and the bands corresponding to
-lactamase activity were visualized by overlaying the gel with
Whatman paper impregnated with nitrocefin.
The isoelectric point of each peak was estimated with the help of TEM
and Bacteroides fragilis
-lactamases, which have low pI
values, for comparison. Three TEM
-lactamases (TEM-1, pI 5.4; TEM-3,
pI 6.3; TEM-12, pI 5.2) and B. fragilis
-lactamase (pI 4.3) were run in parallel with each peak on the isoelectric focusing gel. After focusing and nitrocefin staining, the pI values were estimated graphically by using the known
-lactamases as references.
Expression, renaturation, and purification of Y49
-lactamase.
Two oligonucleotide primers Y49F
(GATCTCGAGAATGCGCAACAGAGGATTCGGTCGT) and Y49R
(GATGAATTCCTATGCAAGCACACCGGCAAC) (where
underscores indicate the restriction sites) were constructed on the
basis of the DNA sequence of a
-lactamase gene in cosmid Y49 of a
library of chromosomal DNA of M. tuberculosis H37Rv
that has been sequenced by the Sanger Centre, Cambridge, United Kingdom
(27). On the basis of our finding that the major
-lactamase is an exoenzyme, the Y49F primer was designed on the
basis of the codons slightly inside of the deduced N terminus of the
Y49 open reading frame so that the N terminus of the recombinant
protein would align with a plausible signal peptide cleavage site. An
XhoI site was added in the Y49F primer, and an
EcoRI site was added in the Y49R primer. These primers were
used to amplify the Y49
-lactamase gene from the chromosomal DNA of
M. tuberculosis H37Ra, producing a 900-bp product which
was digested with XhoI and EcoRI and cloned into
the E. coli expression vector ptrchisB vector
(Invitrogen). The authenticity of the amplified PCR product has been
verified by sequencing the insert in the ptrchisB vector.
The construct was transformed into E. coli Top 10, and the
expression of the recombinant six-histidine tag-Y49
-lactamase
fusion protein was induced with
isopropyl-
-D-thiogalactopyranoside. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) of the cell
lysate indicated that most of the recombinant protein was found in a
pellet as insoluble inclusion bodies. Thus, a protocol was developed to
renature the protein on the nickel affinity column. The inclusion body
pellet was dissolved in 8 M guanidine hydrochloride-500 mM NaCl-25 mM
Tris (pH 8.0) containing 25 mM
-mercaptoethanol and loaded onto a
preequilibrated nickel column (Invitrogen). The column was washed twice
with the same buffer and twice with a buffer at pH 6.0. Then, a
renaturation buffer containing 25 mM Tris-500 mM NaCl (pH 8.3) without
-mercaptoethanol was used to wash the column twice. The renatured
recombinant Y49 was eluted with 5 ml of different concentrations (50, 150, 300, and 500 mM) of imidazole containing 500 mM NaCl and 25 mM
Tris (pH 6.0), and 1-ml fractions were collected. Each fraction was
assayed for
-lactamase activity. Most of the recombinant protein was
eluted in the fractions containing 300 mM imidazole. The fractions with
peak activity were pooled and exchanged with 0.1 M sodium phosphate
buffer (pH 6.0).
Enzyme kinetics.
Initial velocities of hydrolysis were
monitored at a wavelength corresponding to the maximal change in
absorbance between the unhydrolyzed substrate and the hydrolyzed
product and included the following: cephaloridine, 254 nm; cefazolin,
272 nm; nitrocefin, 482 nm; cephapirin, 258 nm; cephalothin, 258 nm;
cefamandole 269 nm; benzylpenicillin, 232 nm; amoxicillin, 235 nm;
phenoxymethylpenicillin, 240; and azlocillin, 235 nm (1,
29).
-Lactamase assays were performed in 0.1 M sodium
phosphate buffer (pH 6.0) in 1-cm cuvettes at 37°C with a DU-70
recording spectrophotometer (Beckman Instruments, Fullerton, Calif.).
For substrate profile determinations, 100 µM cephalosporins and 500 µM penicillins were used in the assays. For Km
and Vmax determinations, the initial velocity of
hydrolysis assays were performed with six cephalosporin concentrations
ranging from 11.1 to 100 µM. Penicillin hydrolysis assays were
performed with six to eight initial substrate concentrations
([s]) ranging from 70 to 1,000 µM. The
Vmax and Km for each
substrate-enzyme combination were determined from
[s]/v against [s] plots (Hanes plots) (39), with computerized software (Hyper; Department
of Biochemistry, University of Liverpool, Liverpool, United Kingdom). The turnover number, kcat, was calculated from
Vmax by using a molecular mass of the purified
recombinant Y49
-lactamase of 30,000 g/mol.
Inhibition studies.
Purified recombinant Y49 enzyme was
incubated with inhibitor at 37°C, and the residual activity was
measured with 100 µM nitrocefin as a reporter substrate. The
inactivation was studied with various concentrations of
-lactamase
inhibitor (2 to 10 µM) by withdrawing the sample and determining the
residual activity after different periods of time. The
Ki value was determined as described by Galleni et al. (6). In the case of EDTA, the
-lactamase activity
was assayed in the presence of 1 to 100 mM EDTA as described above.
 |
RESULTS |
-Lactamase production and purification directly from
M. tuberculosis H37Ra.
To determine whether
M. tuberculosis
-lactamase activity is
predominantly extracellular or cell associated, M. tuberculosis H37Ra was grown in 500 ml of Middlebrook 7H9
broth containing OADC supplemented with 0.05% Tween 80. After 3 to 4 weeks, the cultures were harvested, and the
-lactamase activities in
the cell pellet and the broth supernatant were assayed separately. Under these conditions, the bulk of the
-lactamase activity from a
450-ml culture was found in the broth supernatant (554 U) rather than
with the cell pellets (5.6 U).
The presence of albumin from the OADC supplement in the broth medium is
needed for
-lactamase production, but it has complicated the
purification protocol by making it necessary to subsequently separate
the albumin from the
-lactamase. Attempts to eliminate the albumin
entirely by using Sauton's minimal medium and other media without
albumin were unsuccessful due to greatly diminished
-lactamase
production. It was eventually determined that the amount of albumin
added to the Middlebrook 7H9 broth could be reduced from 50 to
12.5 g per liter without adversely affecting
-lactamase
production.
The usual purification protocol includes (i) ammonium sulfate
precipitation of protein directly from the supernatant of 3
to 6 liters
of 3- to 4-week-old cultures of
M. tuberculosis H37Ra,
with most of the

-lactamase activity being precipitated in the
50 to
62.5% fraction, (ii) G-75 Sephadex chromatography (Fig.
1), and (iii) chromatofocusing (Fig.
2).

-Lactamase has been
recovered from
the chromatofocusing column as three activity peaks.
About 78% of the
final

-lactamase activity was identified in
peak 2 (Fig.
2 and Table
1), with 10 and 12% being present in
peaks 1 and 3, respectively.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Partial purification of -lactamase from M. tuberculosis H37Ra by gel filtration chromatography. Ammonium
sulfate-precipitated protein from 5 liters of culture supernatant was
suspended in 0.1 M sodium citrate and was loaded onto a G-75 Sephadex
column. The eluted protein was collected in 10-ml fractions. The
A280 value and the -lactamase activity of
each fraction are plotted. The large protein peak occurring before the
peak of -lactamase activity primarily comprises the bovine serum
albumin added as a supplement to the broth culture.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Further purification of -lactamase from M. tuberculosis H37Ra by chromatofocusing. Fractions with
-lactamase activity and a relatively low albumin concentration from
gel filtration chromatography (e.g., fractions 29 to 36, Fig. 1) were
pooled, concentrated, and loaded onto a Mono P column. The proteins
were eluted in a linear pH gradient as 2-ml fractions. The
-lactamase activity of each fraction is plotted. Three peaks of
-lactamase activity were identified.
|
|
Isoelectric focusing.
Isoelectric focusing was performed with
each peak fraction from the chromatofocusing. The three peaks
corresponded to pI values of 5.1, 4.9, and 4.5, respectively (Fig.
3). Also, on some isoelectric focusing
runs a minor band at pI 4.7 was observed, but it was never isolated
from the chromatofocusing in quantities adequate for kinetic evaluation
(data not shown). When DEAE anion-exchange chromatography instead of
chromatofocusing was used to further purify the
-lactamase,
isoelectric focusing of the post-DEAE fractions with peak activity
identified the two bands corresponding to pI values of 5.1 and 4.9, respectively, whereas the pI 4.5 band was not observed (data not
shown).

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 3.
Isoelectric focusing of M. tuberculosis
-lactamases. A portion of the fractions corresponding to the three
peaks of -lactamase activity harvested during chromatofocusing were
loaded onto a polyacrylamide gel. The proteins were separated by
isoelectric focusing, and bands corresponding to the -lactamase
activity were identified by overlaying the gel with filter paper soaked
with a solution of nitrocefin.
|
|
Expression, renaturation, and purification of recombinant Y49
-lactamase.
The recombinant Y49
-lactamase was expressed as
a fusion protein containing a six-histidine tag at the N terminus to
facilitate easy purification on a nickel affinity column. The yield was
2 mg of recombinant protein per 100 ml of broth; however, most of it
was found in inclusion bodies. Attempts to renature the purified recombinant after purification and elution from the nickel column were
unsuccessful. Thus, a procedure was developed to renature the
recombinant protein while it was attached to the nickel column. The
purified, soluble, biologically active renatured form of the Y49
-lactamase had a specific activity of 23,000 U per mg and yielded a
single band above the 31-kDa marker on SDS-PAGE (Fig. 4).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
SDS-PAGE of recombinant Y49 -lactamase. The
-lactamase-containing fractions from nickel affinity chromatography
were pooled, and 1 µg of protein was loaded onto an SDS-12%
polyacrylamide gel. Lane 1, molecular mass markers; lane 2, purified
recombinant Y49 -lactamase. The six-histidine tag adds approximately
3 kDa to the mass of the recombinant Y49 -lactamase.
|
|
Kinetic characteristics.
To determine whether the three
activity peaks from the chromatofocusing column of material purified
directly from M. tuberculosis represent different
-lactamases or the same
-lactamase, each peak fraction was
evaluated kinetically. The kinetic characteristics of the first (pI
5.1) and second (pI 4.9) peak fractions were identical to each other,
whereas the third peak exhibited a different kinetic profile (Table
2). Peaks 1 and 2 exhibited greater
penicillinase activity, whereas peak 3 showed relatively greater
cephalosporinase activity. The substrate profile of the recombinant Y49
-lactamase is similar to those of peaks 1 and 2, indicating that the
-lactamase gene on cosmid Y49 encodes most of the
-lactamase
activity that can be recovered directly from M. tuberculosis.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Substrate profiles of -lactamases recovered directly
from M. tuberculosis and recombinant Y49 -lactamase
|
|
The recombinant Y49

-lactamase showed greater activity against most
penicillins compared to its activity against the cephalosporin
substrates (Table
3). It was particularly
active against azlocillin,
with a
kcat value of
55 molecules of azlocillin hydrolyzed per
second for every molecule of

-lactamase. Among the cephalosporins
other than nitrocefin, the
enzyme showed the greatest activity
against cefamandole. The
Ki values for recombinant Y49

-lactamase
with
clavulanic acid and sulbactam were 0.4 and 0.5 µM, respectively.
Clavulanic acid and sulbactam were also capable of inhibiting
the peak
3

-lactamase purified directly from
M. tuberculosis,
with
Ki values of 1.1 and 3.6 µM,
respectively.
meta-Aminophenyl
boronic acid inhibited the
activity of the recombinant Y49

-lactamase
at high concentrations
(i.e., 50% inhibition with 1,000 µM). The
recombinant Y49 enzyme was
not inhibited by EDTA even at high
concentrations (100 mM).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Kinetic characteristics of recombinant Y49 -lactamase
from E. coli and -lactamase obtained directly
from M. tuberculosis
|
|
 |
DISCUSSION |
The major
-lactamase of M. tuberculosis is a
class A
-lactamase which accounts for more than 80% of the total
-lactamase activity associated with broth cultures. Its nucleotide
sequence has been determined and is encoded on cosmid Y49 (GenBank
accession no. Z73966) of a chromosomal DNA library from M. tuberculosis H37Rv (27) and sequenced by the Sanger
Centre. As observed with other class A
-lactamases, the Y49
-lactamase has a molecular mass of about 30 kDa and a serine active
site, and it is inhibited by clavulanic acid and
m-aminophenylboronic acid but not by EDTA. It has
predominant penicillinase activity and is identified by dual bands on
isoelectric focusing with pI values of 5.1 and 4.9. Of interest, the
demonstration of kcat and
Vmax values of the Y49
-lactamase for
azlocillin higher than those for any other
-lactam probably explains
why azlocillin can be added to primary mycobacterial isolation media
including the BACTEC AFB system to inhibit the growth of other
bacteria without having a serious adverse effect upon the recovery of
clinical isolates of M. tuberculosis. The Y49 enzyme is
probably produced by most M. tuberculosis strains and
appears to be the enzyme that has been studied in earlier work
regarding M. tuberculosis
-lactamase (15, 20,
40, 42).
The Y49
-lactamase is associated with two distinct bands on
isoelectric focusing. Zhang et al. (42) showed pI 5.1 and
4.9 bands to be present in each of 10 epidemiologically distinct
isolates of M. tuberculosis. More recently, Hackbarth
et al. (7) sequenced the
-lactamase gene from
M. tuberculosis H37Ra (GenBank accession no. U67924)
and found it to be identical to that of H37Rv. When this gene was
expressed in Mycobacterium smegmatis, they found that
isoelectric focusing results were a composite of those for
M. smegmatis (bands at pI values of 5.4 and 4.3) and
M. tuberculosis (bands at pI values of 5.1 and 4.9).
The derivation of both the pI 5.1 and 4.9 bands from the same gene is
further supported by our finding that the substrate profiles of the pI
5.1 and 4.9 bands when separated by chromatofocusing were identical.
Apparently, the Y49
-lactamase gene gives rise to two stably
modified forms of the same enzyme. Protein oxidation and/or ragged N
termini of the same
-lactamase related to protease activity might
account for multiple bands on isoelectric focusing of a single
-lactamase. A highly plausible possibility is that one represents a
true exoenzyme form of the enzyme, whereas the other is cross-linked at
the N terminus to a membrane-associated lipid. This is the case for other gram-positive bacteria which produce extracellular
-lactamases (24). For example, in many strains of Staphylococcus
aureus, about 50% of the
-lactamase exists in the
extracellular form and about 50% exists in the membrane-bound form.
Minor but insignificant differences in the kinetic properties of the
extracellular and membrane-bound forms of staphylococcal
-lactamase
have been reported (16), even though they represent stable
forms of the same
-lactamase. We might be observing a similar
phenomenon with the Y49
-lactamase.
There is growing evidence that M. tuberculosis produces
one or more
-lactamases in addition to the Y49 enzyme. We identified an enzyme that had a pI value of 4.5 and predominant cephalosporinase activity but that is clearly different from the Y49 enzyme. It was
harvested in the same fractions off the G-75 Sephadex column as the Y49
enzyme, suggesting a molecular mass also in the 30-kDa range. Our
studies indicate that this enzyme is also inhibited by clavulanic acid
and sulbactam. Furthermore, we also observed slight
-lactamase
activity in fractions from G-75 Sephadex chromatography eluting before
the major
-lactamase (e.g., fractions 26 and 27 in Fig. 1, whereas
the major
-lactamase eluted in fractions 29 to 35). Upon isoelectric
focusing of these fractions a band of nitrocefin hydrolysis with a pI
value of >6.0 was observed (data not shown). The presence of this band
with a higher pI value only in the initial fractions with
-lactamase
activity and its incomplete separation from the albumin peak that
accounts for most of the absorbance in these fractions suggests that it
has a higher molecular mass than the Y49
-lactamase.
Candidates for other
-lactamase genes can be found among data made
available through M. tuberculosis genome sequencing
efforts. BLAST searches of the Sanger Centre site on the World Wide Web by using the amino acid sequence of Mycobacterium fortuitum
-lactamase (1, 6) as the search parameter identifies a
candidate open reading frame (ORF) in cosmid Y6F7 (now recorded under
GenBank accession no. Z95555) encoding a protein of unknown function. Although large, with a deduced sequence of 491 amino acids, this protein contains structural features common to class A
-lactamases (i.e., S-x-x-K active site, S-D-N loop, -E- acidic residue, and D-K-T-G
motif [11]).
In addition, the Sanger Centre has reported the presence of part of an
ORF with homology to class C
-lactamases in cosmid Y31 (GenBank
accession no. Z73101). Because only a portion of the ORF was contained
within Y31, we amplified this portion by PCR and used it as a probe to
identify and clone a 3.5-kb BamHI fragment of M. tuberculosis chromosomal DNA containing the remainder of the gene
(17). Sequencing of an additional 900 bp of this gene
followed by using this sequence as the search parameter for another
BLAST search at the Sanger Centre Web site revealed identity with part
of another cosmid (Y21C12; now recorded under GenBank accession no.
Z95210). The complete ORF of the gene bridging cosmids Y31 and Y21C12
encodes a protein bearing homology to the class C
-lactamases of
gram-negative aerobic species as well as carboxypeptidases.
Furthermore, another M. tuberculosis ORF with strong
homology to class C
-lactamases is located on cosmid 4C12 (now
recorded under GenBank accession no. Z81360).
It is not yet clear whether any of these gene products correlates with
the bands with pI values of 4.5 and >6.0 and
-lactamase activity
which we observe on isoelectric focusing. Their estimated molecular
masses are 53 to 55 kDa; this includes the mass of the leader peptide.
This is larger than most class C
-lactamases, and it could be that
they are carboxypeptidases (i.e.,
D-alanyl-D-alanine peptidases) with some
-lactamase activity. Chambers et al. identified a 52-kDa PBP in cell
membranes of M. tuberculosis (3), and on
gels this band had the appearance of a doublet (4), further suggesting the presence of penicillin-interactive proteins of about
this size. The issue of whether these proteins represent carboxypeptidases or
-lactamases may best be answered by determining the turnover numbers (kcat values) for
-lactams by using purified enzymes, although the answer might
be ambiguous because some carboxypeptidases hydrolyze
-lactams
fairly efficiently. Because the amounts of these enzymes that can be
recovered directly from M. tuberculosis in
culture are too small to permit a more detailed analysis than that
reported in this paper, overexpression of the genes in recombinant form
may be the most plausible strategy for evaluating these proteins further.
We found that most of the
-lactamase activity recovered directly
from M. tuberculosis was found in the broth culture
rather than in the cell pellet. This is in contrast to the reports of some earlier investigations, in which the
-lactamase was believed to
be either intracellular or membrane bound (10, 12, 15, 40).
The difference between the findings presented in those other reports
and our observations may be due, in part, to the use of Tween 80 in the
broth medium. Tween 80 is a nonionic detergent that minimizes cell
clumping and acts to disperse tubercle bacilli as single cells
(18, 34). Kasik et al. (14) reported that "cell-free mycobacterial penicillinase" could be obtained by
incubating M. tuberculosis in liquid Dubos media
containing Tween-albumin. In contrast, glycerol- and oleic acid-based
media promote the clumping of cells into macroscopic aggregates. Our
results are consistent with studies showing that the
-lactamases of
other mycobacterial species including M. fortuitum and
M. smegmatis are also predominantly extracellular
(1, 28).
Finally, the therapeutic options for the management of tuberculosis
caused by multidrug-resistant strains are often limited.
-Lactam antibiotics are extensively developed, highly effective, widely used, and relatively nontoxic antimicrobial agents. The evaluation of
-lactam activity against M. tuberculosis in vitro and the further study of mycobacterial
-lactamases should help in identifying which
-lactams have the
greatest promise of efficacy in vivo.
 |
ACKNOWLEDGMENTS |
This research was supported by U.S. Public Health Service grant
AI-35250 from the National Institutes of Health.
We are grateful to Hiriam Gates for assistance in the purification of
M. tuberculosis
-lactamase. We thank Charles W. Stratton for technical advice with isoelectric focusing and for
providing us with
-lactamases with low pI values that were used as
standards to calculate the pI values of the M. tuberculosis enzymes. We thank Stewart Cole of the Institut
Pasteur in Paris, France, for notifying us in June 1996 that a gene
with homology to known
-lactamases had been identified on cosmid
Y49. We thank the Sanger Centre for maintaining a Web site with a BLAST
search engine from which the DNA sequences of the Y49
-lactamase and
other mycobacterial genes could be retrieved.
 |
FOOTNOTES |
*
Corresponding author. A-3310 MCN, Vanderbilt
University, 1161 21st Ave. South, Nashville, TN 37212-2605. Phone:
(615) 327-4751, ext. 5486. Fax: (615) 343-6160. E-mail:
doug.kernodle{at}vanderbilt.edu.
 |
REFERENCES |
| 1.
|
Amicosante, G.,
N. Franceschini,
B. Segatore,
A. Oratore,
L. Fattoroni,
G. Orefici,
J. Van Beeumen, and J. M. Frére.
1990.
Characterization of beta-lactamase produced in Mycobacterium fortuitum D316.
Biochem. J.
271:729-734[Medline].
|
| 2.
|
Bloom, B. R., and C. J. L. Murray.
1992.
Tuberculosis: commentary on a reemergent killer.
Science
257:1055-1064[Abstract/Free Full Text].
|
| 3.
|
Chambers, H. F.,
D. Moreau,
D. Yajko,
C. Miick,
C. Wagner,
C. Hackbarth,
S. Kocagoz,
E. Rosenberg,
W. K. Hadley, and H. Nikaido.
1995.
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
Antimicrob. Agents Chemother.
39:2620-2624[Abstract].
|
| 4.
| Chambers, H. F. Personal communication.
|
| 5.
|
Cynamon, M. H., and G. S. Palmer.
1983.
In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis.
Antimicrob. Agents Chemother.
24:429-431[Abstract/Free Full Text].
|
| 6.
|
Galleni, M.,
N. Franceschini,
B. Quinting,
L. Fattorini,
G. Orefici,
A. Oratore,
J. M. Frére, and G. Amicosante.
1994.
Use of chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.
Antimicrob. Agents Chemother.
38:1608-1614[Abstract/Free Full Text].
|
| 7.
|
Hackbarth, C. J.,
I. Unsal, and H. F. Chambers.
1997.
Cloning and sequence analysis of a class A -lactamase from Mycobacterium tuberculosis H37Ra.
Antimicrob. Agents Chemother.
41:1182-1185[Abstract].
|
| 8.
|
Heifets, L. B.,
M. D. Iseman,
J. L. Cook,
P. J. Lindholm-Levy, and I. Drupa.
1985.
Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods.
Antimicrob. Agents Chemother.
27:11-15[Abstract/Free Full Text].
|
| 9.
|
Iland, C. N.
1946.
The effect of penicillin on the tubercle bacillus.
J. Pathol. Bacteriol.
58:495-500.
|
| 10.
|
Iland, C. N., and S. Baines.
1949.
The effect of penicillin on the tubercle bacillus: tubercle penicillinase.
J. Pathol. Bacteriol.
61:329-335.
|
| 11.
|
Joris, B.,
P. Ledent,
O. Dideberg,
E. Fonzé,
J. Lamotte-Brasseur,
J. A. Kelly,
J. M. Ghuysen, and J. M. Frère.
1991.
Comparison of the sequences of class A -lactamases and of the secondary structure elements of penicillin-recognizing proteins.
Antimicrob. Agents Chemother.
35:2294-2301[Abstract/Free Full Text].
|
| 12.
|
Kasik, J. E.
1965.
The nature of mycobacterial penicillinase.
Am. Rev. Respir. Dis.
91:117-119[Medline].
|
| 13.
|
Kasik, J. E.,
M. Weber,
E. Winberg, and W. R. Barclay.
1966.
The synergistic effect of dicloxacillin and penicillin G on murine tuberculosis.
Am. Rev. Respir. Dis.
94:260-261[Medline].
|
| 14.
|
Kasik, J. E.,
M. Weber, and P. J. Freehill.
1967.
The effect of the penicillinase-resistant penicillins and other chemotherapeutic substances on the penicillinase of the R1Rv strain of Mycobacterium tuberculosis.
Am. Rev. Respir. Dis.
95:12-19[Medline].
|
| 15.
|
Kasik, J. E.
1979.
Mycobacterial beta-lactamases, p. 339-350.
In
J. M. T. Hamilton-Miller, and J. T. Smith (ed.), Beta-lactamases. Academic Press, London, United Kingdom.
|
| 16.
|
Kernodle, D. S.,
P. A. McGraw,
C. W. Stratton, and A. B. Kaiser.
1990.
Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants.
Antimicrob. Agents Chemother.
34:420-425[Abstract/Free Full Text].
|
| 17.
| Kernodle, D. S., and R. K. R. Voladri. Unpublished data.
|
| 18.
|
Kirby, W. M. M., and R. J. Dubos.
1947.
Effect of penicillin on the tubercle bacillus in vitro.
Proc. Soc. Exp. Biol. Med.
66:120-123.
|
| 19.
|
Kochi, A.
1991.
The global tuberculosis situation and the new control strategy of the World Health Organization.
Tubercle
72:1-6[Medline].
|
| 20.
|
Kwon, H. H.,
H. Tomioka, and H. Saito.
1995.
Distribution and characterization of -lactamases of mycobacteria and related organisms.
Tuberc. Lung Dis.
76:141-148[Medline].
|
| 21.
|
Lorian, V., and L. D. Sabath.
1972.
The effect of some penicillins on Mycobacterium tuberculosis.
Am. Rev. Respir. Dis.
105:632-637[Medline].
|
| 22.
|
Mishra, R. K., and J. E. Kasik.
1970.
The mechanisms of mycobacterial resistance to penicillins and cephalosporins.
Int. J. Clin. Pharmacol.
3:73-77.
|
| 23.
|
Misiek, M.,
A. J. Moses,
T. A. Pursiano,
F. Leitner, and K. E. Price.
1973.
In vitro activity of cephalosporins against Mycobacterium tuberculosis H37Rv: structure-activity relationships.
J. Antibiot.
26:737-744[Medline].
|
| 24.
|
Neilsen, J. B. K., and J. O. Lampen.
1982.
Membrane-bound penicillinases in gram-positive bacteria.
J. Biol. Chem.
257:4490-4495[Abstract/Free Full Text].
|
| 25.
|
Nitta, A. T.,
M. D. Iseman,
J. D. Newell,
L. A. Madsen, and M. Goble.
1993.
Ten-year experience with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary tuberculosis.
Clin. Infect. Dis.
16:219-222[Medline].
|
| 26.
|
O'Callaghan, C. H.,
A. Morris,
S. M. Kirby, and A. H. Singler.
1972.
Novel method for detection of -lactamase by using a chromogenic cephalosporin substrate.
Antimicrob. Agents Chemother.
1:283-288[Abstract/Free Full Text].
|
| 27.
|
Philipp, W. J.,
S. Poulet,
K. Eiglmeier,
L. Pascopella,
V. Balasubramanian,
B. Heym,
S. Bergh,
B. R. Bloom,
W. R. Jacobs, Jr., and S. T. Cole.
1996.
An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae.
Proc. Natl. Acad. Sci. USA
93:3132-3137[Abstract/Free Full Text].
|
| 28.
|
Quining, B.,
M. Galleni,
J. Timm,
B. Gicquel,
G. Amicosante, and J. M. Frére.
1997.
Purification and properties of the Mycobacterium smegmatis mc(2)155 beta-lactamase.
FEMS Microbiol. Lett.
149:11-5[Medline].
|
| 29.
|
Ross, G. W.,
K. V. Chanter,
A. M. Harris,
S. M. Kirby,
M. J. Marshall, and C. H. O'Callaghan.
1974.
Comparison of assay techniques for beta-lactamase activity.
Anal. Biochem.
54:9-16.
|
| 30.
|
Sanders, W. E., Jr.,
N. Schneider,
C. Hartwig,
R. Cacciatore, and H. Valdez.
1980.
Comparative activity of cephalosporins against mycobacteria, p. 1075-1077.
In
J. D. Nelson, and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington, D.C.
|
| 31.
|
Solotrovsky, M., and C. N. Iland.
1948.
The effect of penicillin on the growth of Mycobacterium tuberculosis in Dubos' medium.
J. Bacteriol.
55:555-559[Free Full Text].
|
| 32.
|
Soltys, M. A.
1952.
Effect of penicillin on mycobacteria in vitro and vivo.
Tubercle
33:120-125.
|
| 33.
|
Sorg, T. B., and M. H. Cynamon.
1987.
Comparison of four -lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
J. Antimicrob. Chemother.
19:59-64[Abstract/Free Full Text].
|
| 34.
|
Stinson, M. W., and M. Solotorovsky.
1971.
Interaction of Tween 80 detergent with mycobacteria in synthetic medium.
Am. Rev. Respir. Dis.
104:717-727[Medline].
|
| 35.
|
Sudre, P.,
G. ten Dam, and A. Kochi.
1992.
Tuberculosis: a global overview of the situation today.
Bull. W. H. O.
70:149-159[Medline].
|
| 36.
|
Watt, B.,
J. R. Edwards,
A. Rayner,
A. J. Grindey, and G. Harris.
1992.
In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule.
Tuberc. Lung Dis.
73:134-136[Medline].
|
| 37.
|
Winder, F. G.
1982.
Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria, p. 53-138.
In
C. Ratledge, and J. Stanford (ed.), The biology of the mycobacteria Academic Press, Inc., New York, N.Y.
|
| 38.
|
Wong, C. S.,
G. S. Palmer, and M. H. Cynamon.
1988.
In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid.
J. Antimicrob. Chemother.
22:863-866[Abstract/Free Full Text].
|
| 39.
|
Wong, J. T.
1985.
Kinetics of enzyme mechanisms.
Academic Press, Inc., New York, N.Y.
|
| 40.
|
Woodruff, H. B., and J. W. Foster.
1945.
Microbiological aspects of penicillin. VII. Bacterial penicillinase.
J. Bacteriol.
49:7-29[Free Full Text].
|
| 41.
|
Yew, W. W.,
C. F. Wong,
J. Lee,
P. C. Wong, and C. H. Chau.
1995.
Do -lactam- -lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis?
Tuberc. Lung Dis.
76:90-92[Medline].
|
| 42.
|
Zhang, Y.,
V. A. Steingrube, and R. J. Wallace, Jr.
1992.
Beta-lactamase inhibitors and the inducibility of the beta-lactamase of Mycobacterium tuberculosis.
Am. Rev. Respir Dis.
145:657-660[Medline].
|
Antimicrobial Agents and Chemotherapy, June 1998, p. 1375-1381, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
McDonough, J. A., McCann, J. R., Tekippe, E. M., Silverman, J. S., Rigel, N. W., Braunstein, M.
(2008). Identification of Functional Tat Signal Sequences in Mycobacterium tuberculosis Proteins. J. Bacteriol.
190: 6428-6438
[Abstract]
[Full Text]
-
Wang, F., Cassidy, C., Sacchettini, J. C.
(2006). Crystal Structure and Activity Studies of the Mycobacterium tuberculosis {beta}-Lactamase Reveal Its Critical Role in Resistance to {beta}-Lactam Antibiotics.. Antimicrob. Agents Chemother.
50: 2762-2771
[Abstract]
[Full Text]
-
Sauvage, E., Fonze, E., Quinting, B., Galleni, M., Frere, J.-M., Charlier, P.
(2006). Crystal Structure of the Mycobacterium fortuitum Class A {beta}-Lactamase: Structural Basis for Broad Substrate Specificity.. Antimicrob. Agents Chemother.
50: 2516-2521
[Abstract]
[Full Text]
-
McDonough, J. A., Hacker, K. E., Flores, A. R., Pavelka, M. S. Jr, Braunstein, M.
(2005). The Twin-Arginine Translocation Pathway of Mycobacterium smegmatis Is Functional and Required for the Export of Mycobacterial {beta}-Lactamases. J. Bacteriol.
187: 7667-7679
[Abstract]
[Full Text]
-
Flores, A. R., Parsons, L. M., Pavelka,, M. S. Jr
(2005). Genetic analysis of the {beta}-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to {beta}-lactam antibiotics. Microbiology
151: 521-532
[Abstract]
[Full Text]
-
Philalay, J. S., Palermo, C. O., Hauge, K. A., Rustad, T. R., Cangelosi, G. A.
(2004). Genes Required for Intrinsic Multidrug Resistance in Mycobacterium avium. Antimicrob. Agents Chemother.
48: 3412-3418
[Abstract]
[Full Text]
-
Goffin, C., Ghuysen, J.-M.
(2002). Biochemistry and Comparative Genomics of SxxK Superfamily Acyltransferases Offer a Clue to the Mycobacterial Paradox: Presence of Penicillin-Susceptible Target Proteins versus Lack of Efficiency of Penicillin as Therapeutic Agent. Microbiol. Mol. Biol. Rev.
66: 702-738
[Abstract]
[Full Text]
-
Bebrone, C., Moali, C., Mahy, F., Rival, S., Docquier, J. D., Rossolini, G. M., Fastrez, J., Pratt, R. F., Frère, J.-M., Galleni, M.
(2001). CENTA as a Chromogenic Substrate for Studying {beta}-Lactamases. Antimicrob. Agents Chemother.
45: 1868-1871
[Abstract]
[Full Text]